可用微針測量的慢性病生物標誌物市場

本報告探討了可微針測量的慢性病生物標誌物市場，並提供了市場概況、細分市場概況、技術概況、市場機會以及進入市場的公司概況。我是。

目錄

• 執行摘要
• 可通過微針測量的慢性疾病生物標誌物
• 執行摘要
• 護理點診斷市場機制
• 生物標誌物及其在臨床醫學中的潛力
• 用於檢測和測量生物標誌物的微針
• 微針產品類別
• 實心微針
• 中空微針
• 塗層微針
• 可溶性微針
• 彈力針
• 碳納米管
• 離子蝕刻
• C-MEMS
• 特殊微針
• 相變
• 基於微處理器的設備
• 複合微針
• 光敏微針
• 靈活數組
• 微針陣列和陣列幾何
• 數組架構
• 微針和微流體
• 可穿戴式微針
• 組織液的作用
• 微針診斷-設計元素
• 分析物捕獲
• 樣品採集
• 體液吸收
• 電化學傳感方式
• 光學感應方式
• 慢性病相關生物標誌物
• 生物標誌物檢測
• 微針製造
• 微成型
• 微成形
• 微加工
• 結構膜
• 新的製造方法
• 3D打印
• 靜電紡絲陣列
• 雙光子聚合（2PP）
• 磁化自組織
• 附加製造方法
• 立體光刻
• 熔體沉積建模
• 數字光處理
• 選擇性激光燒結
• 選擇性激光熔化
• 噴墨打印
• 表面改性
• 診斷性微針裝置分析
• 微型經皮接口平台 (MicroTIP)
• 明德拉健康
• Scibase (尼維森)
• 第七感生物系統
• Sysmex
• 慢性病生物標誌物
• 許多治療領域的市場機會
• 麻醉
• 心髒病
• 內分泌
• 胃腸疾病
• 婦科
• 血
• 先天性代謝異常
• 感染
• 神經內科
• 腫瘤學
• 風濕病學
• 微針生物標誌物診斷
• 主要治療領域
• 葡萄糖
• 免疫因子
• 電解質/鉀
• 生物標誌物診斷
• 公司簡介
• 市場參與者簡介

Chronic Diseases, Biomarkers and the FDA

Biomarkers are a key medical product development tool capable of facilitating development of medical products and spurring innovation. When used in the right context, biomarkers have the potential to help expedite patient access to safe and effective treatments by reducing the time and cost of clinical trials while maintaining patient protections. FDA encourages the integration of biomarkers in medical product development and approval, to facilitate the monitoring of FDA-regulated products, and their appropriate use in clinical practice. Biomarkers promise to reduce stagnation and foster innovation in the development of new medical products. A biomarker can be used as the basis for creating a routine diagnostic test for clinical use, after it has been approved as an in-vitro diagnostic. A biomarker can also be used to develop a companion diagnostic test that enables better decision-making on the use of a therapy that is tailored to the patient.

What You Will Learn:

• What companies are active in the microneedle diagnostics segments, what distinguishes their technology, and what is their market presence?

• What are the identified and verified chronic disease biomarkers, and what are their properties ?

• What are the major factors that are influencing interest in chronic disease biomarkers?

• What are the design factors, material selection issues, technologies, and market development issues for microneedles capable of capturing and identifying chronic disease biomarkers?

• What are the important therapeutic markets for microneedle measurable chronic disease biomarkers? What is their market potential?

• What are the significant economic, technology, and regulatory factors affecting the market for diagnostic microneedles?

Table of Contents

• Executive Summary
• Microneedle Measurable Chronic Disease Biomarkers
• Executive Summary
• Point-of-Care Diagnostics Market Dynamics
• Biomarkers and their Potential in Clinical Medicine
• Microneedles for Detecting and Measuring Biomarkers
• Microneedle Product Categories
• Solid Microneedles
• Hollow Microneedles
• Coated Microneedles
• Dissolving Microneedles
• Stretched Needles
• Carbon Nanotubes
• Ion Etching
• C-MEMS
• Specialty Microneedles
• Phase Transition
• Microprocessor-based Devices
• Composite Microneedles
• Light-responsive Microneedles
• Flexible Arrays
• Microneedle Arrays & Array Geometries
• Array Architectures
• Microneedles & Microfluidics
• Wearable Microneedles
• The Role of Interstitial Fluid
• Microneedle Diagnostics - Design Factors
• Analyte Capture
• Sample Acquisition
• Biofluid Absorption
• Electrochemical Sensing Methods
• Optical Sensing Methods
• Chronic Disease Associated Biomarkers
• Biomarker Detection
• Microneedle Fabrication
• Micromolding
• Microforming
• Micromachining
• Structured Films
• Emerging Fabrication Methods
• 3D Printing
• Electrospun Arrays
• Two-Photon Polymerization (2PP)
• Magnetization-induced Self-assembly
• Additive Fabrication Methods
• Stereolithography
• Fused Deposition Modelling
• Digital Light Processing
• Selective Laser Sintering
• Selective Laser Melting
• Inkjet Printing
• Surface Modification
• Diagnostic Microneedle Device Analysis
• Micro Transdermal Interface Platform (MicroTIPs)
• Mindera Health
• Scibase (Nevisense)
• Seventh Sense Biosystems
• Sysmex
• Chronic Disease Biomarkers
• Opportunities Extend Across Numerous Therapeutic Areas
• Anesthesiology
• Cardiology
• Endocrinology
• Gastroenterology
• Gynecology
• Hematology
• Inborn Errors of Metabolism
• Infectious Diseases
• Neurology
• Oncology
• Rheumatology
• Microneedle Biomarker Diagnostics
• Key Therapeutic Sectors
• Glucose
• Immune Factors
• Electrolytes/Potassium
• Biomarker-enabled Diagnostics
• Company Profiles
• Market Participant Profiles